Intraoperative radiation therapy for osteosarcoma.
Yamamuro
T
T
Kotoura
Y
Y
D000293:Adolescent; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000671:Amputation, Surgical; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D001859:Bone Neoplasms / Q000097:blood / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002648:Child; D002945:Cisplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D005598:Fractures, Spontaneous / Q000209:etiology; D006801:Humans; D007432:Intraoperative Period; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D009364:Neoplasm Recurrence, Local; D012516:Osteosarcoma / Q000097:blood / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D011832:Radiation Injuries / Q000209:etiology; D011882:Radiotherapy, High-Energy / Q000009:adverse effects; D012867:Skin / Q000473:pathology / Q000528:radiation effects; D015996:Survival Rate
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D004317:Doxorubicin; D000469:Alkaline Phosphatase; D002945:Cisplatin